What one share of iSpecimen holds
Our Mission, Vision, and Core Values iSpecimen’s mission is to accelerate life science research, discovery and development with a global marketplace platform that connects researchers to subjects, specimens, and associated data.
iSpecimen’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.90 |
|---|---|
| Profit | −$22.10 |
| Cash and investments | $2.90 |
| Book value | $1.14 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $940.93 | −$926.78 | $19.49 | −$545.73 | — | $1,820 |
| 2023 | $878.47 | −$982.11 | $1.72 | −$515.59 | — | $857.93 |
| 2024 | $522.82 | −$703.26 | $1.78 | −$466.78 | — | — |
| 2025 | $16.76 | −$91.15 | $0.00 | −$36.86 | — | $14.57 |
Common questions about iSpecimen
How much does one share of iSpecimen earn?
Over the last 12 months, iSpecimen lost $22.10 for each share on $0.90 of sales.
Does iSpecimen pay a dividend?
iSpecimen didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is iSpecimen’s book value per share?
iSpecimen’s book value is $1.14 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of iSpecimen have?
Each share of iSpecimen has $2.90 of cash and investments, as of June 30, 2026.
Has iSpecimen bought back shares?
iSpecimen’s share count rose about 941% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.